St. Elizabeth's Regional Medical Center is a general acute care licensed hospital located at 555 South 70th Street in Lincoln, Nebraska, United States. It is a part of Catholic Health Initiatives hospital network. It was founded in 1889 and had 258 staffed beds in 2022.

There are 258 beds in Saint Elizabeth Regional Medical Center.

During the past decade, Saint Elizabeth Regional Medical Center conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 54 clinical trials were completed, i.e. on average, 49.1% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 39 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Elizabeth Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 28 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Elizabeth Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 92 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Saint Elizabeth Regional Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Saint Elizabeth Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Elizabeth Regional Medical Center" are "Drug" (139 trials), "Other" (99 trials), "Biological" (78 trials), "Procedure" (43 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (38 trials), "Computed Tomography" (25 trials), "Nivolumab" (25 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "Saint Elizabeth Regional Medical Center" are 145 trials for "All" genders, 29 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Elizabeth Regional Medical Center". undefined are not yet recruiting, 52 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Saint Elizabeth Regional Medical Center, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Elizabeth Regional Medical Center, 6 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".